• Info
  • Significant Ownership

Significant Ownership of INTRACOASTAL CAPITAL, LLC

Signature - Title
/s/ Mitchell P. Kopin - Mitchell P. Kopin/Manager
Location
Delray Beach, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by INTRACOASTAL CAPITAL, LLC.

Notify me when INTRACOASTAL CAPITAL, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of INTRACOASTAL CAPITAL, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PPBT Purple Biotech Ltd. Ordinary shares, no par value per share 10% $115,100,512 +$34,923,545 200,453,695 +44% Mitchell P. Kopin 30 Sep 2025
TIRX TIAN RUIXIANG Holdings Ltd Class A ordinary shares, par value $0.125 per share 10% $4,242,258 10,100,615 Mitchell P. Kopin 29 Jan 2026
LGVN Longeveron Inc. Class A Common Stock, par value $0.001 per share 10% $1,779,037 2,143,418 Mitchell P. Kopin 08 Aug 2025
ICU SeaStar Medical Holding Corporation Common stock, par value $0.0001 per share 10% $1,765,960 +$738,235 3,098,175 +72% Mitchell P. Kopin 30 Sep 2025
GRI GRI Bio, Inc. Common stock, par value $0.0001 per share 10% $1,415,927 +$1,331,781 677,477 +1583% Mitchell P. Kopin 11 Dec 2025
GOVX GeoVax Labs, Inc. Common stock, par value $0.001 per share 10% $1,349,734 +$26,972 2,849,344 +2% Mitchell P. Kopin 30 Sep 2025
SILO Silo Pharma, Inc. Common stock, par value $0.0001 per share 10% $1,038,308 +$409,747 1,384,410 +65% Mitchell P. Kopin 30 Sep 2025
LUCY Innovative Eyewear, Inc. Common stock, par value $0.00001 per share 10% $1,030,680 +$64,952 507,724 +6.7% Mitchell P. Kopin 30 Sep 2025
ASNS ACTELIS NETWORKS INC Common stock, par value $0.0001 per share 10% $756,532 +$756,532 1,939,826 Mitchell P. Kopin 07 Nov 2025
SBFM Sunshine Biopharma Inc. Common stock, par value $0.001 per share 10% $702,858 505,653 Mitchell P. Kopin 19 May 2025
ASTI Ascent Solar Technologies, Inc. Common stock, par value $0.0001 per share 10% $662,974 +$40,027 338,252 +6.4% Mitchell P. Kopin 30 Sep 2025
PCSA Processa Pharmaceuticals, Inc. Common stock, par value $0.0001 per share 10% $595,986 -$22,753 2,907,250 -3.7% Mitchell P. Kopin 30 Jun 2025
BBLG Bone Biologics Corporation Common stock, par value $0.001 per share 10% $482,187 +$111,397 199,251 +30% Mitchell P. Kopin 30 Sep 2025
APDN Applied DNA Sciences, Inc. Common Stock, par value $0.001 per share 10% $457,242 143,336 Mitchell P. Kopin 08 Jul 2025
BJDX Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share 10% $273,473 177,580 Mitchell P. Kopin 10 Oct 2025
SOBR SOBR Safe, Inc. Common stock, par value $0.00001 per share 10% $270,010 188,818 Mitchell P. Kopin 29 Dec 2025
SXTP 60 Degrees Pharmaceuticals, Inc. Common stock, par value $0.0001 per share 10% $204,995 +$37,402 455,545 +22% Mitchell P. Kopin 30 Sep 2025
CETX Cemtrex Inc. Common stock, par value $0.001 per share 10% $33,627 -$104,461 82,018 -76% Mitchell P. Kopin 30 Sep 2025
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share 10% 244,771 Mitchell P. Kopin 11 Sep 2025
PMCB PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share 10% 695,715 -2.7% Mitchell P. Kopin 30 Sep 2025
NCPL Netcapital Inc. Common stock, par value $0.001 per share 9.3% $1,194,239 +$509,092 501,781 +74% Mitchell P. Kopin 30 Sep 2025
MBOT Microbot Medical Inc. Common stock, par value $0.01 per share 8.2% $12,004,370 +$12,004,370 6,002,185 Mitchell P. Kopin 15 Jan 2026
AEMD Aethlon Medical, Inc. Common Stock, par value $0.001 per share 7.7% 576,603 Mitchell P. Kopin 04 Sep 2025
LMFA LM Funding America, Inc. Common Stock, par value $0.001 per share 7.6% $1,119,559 +$730,336 1,166,207 +188% Mitchell P. Kopin 19 Dec 2025
PHIO Phio Pharmaceuticals Corp. Common stock, par value $0.0001 per share 7% $1,014,800 -$236,404 430,000 -19% Mitchell P. Kopin 30 Sep 2025
NAYA NAYA Biosciences Inc. Common stock, par value $0.0001 per share 6.9% $166,478 504,478 Mitchell P. Kopin 12 Jan 2025
DRMA Dermata Therapeutics, Inc. Common stock, par value $0.0001 per share 5.5% $102,941 +$86,603 147,059 +530% Mitchell P. Kopin 24 Dec 2025
SVRE SaverOne 2014 Ltd. Ordinary shares, par value NIS 0.01 per share 5% $11,347,045 35,459,516 Mitchell P. Kopin 30 Jan 2025
BLRX BioLineRx Ltd. Ordinary shares, par value NIS 0.10 per share 5% $11,245,973 102,236,115 Mitchell P. Kopin 06 Jan 2025
BNGO Bionano Genomics, Inc. Common Stock, par value $0.0001 per share 5% $1,957,398 508,415 Mitchell P. Kopin 16 Sep 2025
DPRO Draganfly Inc. Common shares, no par value per share 5% $1,841,824 +$595,338 990,228 +48% Mitchell P. Kopin 17 Jul 2025
SNGX Soligenix, Inc. Common Stock, par value $0.001 per share 5% $1,241,014 446,408 Mitchell P. Kopin 25 Sep 2025
BCDA BioCardia, Inc. Common Stock, par value $0.001 per share 5% $1,086,499 557,179 Mitchell P. Kopin 18 Sep 2025
JZXN Jiuzi Holdings Inc. Ordinary shares, par value $0.00039 per share 5% $1,083,753 1,062,503 Mitchell P. Kopin 29 Sep 2025
IMNN Imunon, Inc. Common stock, par value $0.01 per share 5% $853,757 -$35,133 1,067,196 -4% Mitchell P. Kopin 30 Jun 2025
JAGX Jaguar Health, Inc. Common stock, par value $0.0001 per share 5% $779,374 65,002 Mitchell P. Kopin 20 May 2025
SLRX Salarius Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5% $711,721 187,295 Mitchell P. Kopin 12 Nov 2025
VVOS Vivos Therapeutics Inc. Common stock, par value $0.0001 per share 5% $707,610 297,315 Mitchell P. Kopin 22 Dec 2024
RELI Reliance Global Group, Inc. Common Stock, par value $0.086 per share 5% $477,865 942,906 Mitchell P. Kopin 28 Jan 2026
KTTA Pasithea Therapeutics Corp. Common stock, par value $0.0001 per share 5% $451,365 317,863 Mitchell P. Kopin 06 May 2025
GXAI Gaxos.ai Inc. Common stock, par value $0.0001 per share 5% $392,715 +$76,386 363,625 +24% Mitchell P. Kopin 26 Dec 2024
VERO Venus Concept Inc. Common stock, par value $0.0001 per share 5% $299,980 +$205,918 120,474 +219% Mitchell P. Kopin 06 Jun 2025
ENVB Enveric Biosciences, Inc. Common Stock, par value $0.01 per share 5% $278,572 +$155,982 71,246 +127% Mitchell P. Kopin 27 Jan 2026
NUWE Nuwellis, Inc. Common stock, par value $0.0001 per share 5% $251,087 251,087 Mitchell P. Kopin 09 Jun 2025
MBIO Mustang Bio, Inc Common stock, par value $0.0001 per share 5% $177,716 -$48,781 185,527 -22% Mitchell P. Kopin 30 Jun 2025
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.0009 per share 5% $172,058 209,827 Mitchell P. Kopin 15 Jan 2025
LIXT Lixte Biotechnology Holdings, Inc. Common stock, par value $0.0001 per share 5% $167,903 138,763 Mitchell P. Kopin 11 Feb 2025
ATNF 180 Life Sciences Corp. Common stock, par value $0.0001 per share 5% $117,358 165,293 Mitchell P. Kopin 27 Dec 2024
NAYA INVO Fertility, Inc. Common stock, par value $0.0001 per share 5% $72,411 34,981 Mitchell P. Kopin 31 Mar 2025
KWE DEFSEC Technologies Inc. Common shares, no par value per share 5% 71,693 Mitchell P. Kopin 23 Jul 2025
CLRB Cellectar Biosciences, Inc. Common stock, par value $0.00001 per share 5% 140,101 Mitchell P. Kopin 01 Jul 2025
LFWD Lifeward Ltd. Ordinary Shares, par value NIS 1.75 per share 5% 819,443 +48% Mitchell P. Kopin 25 Jun 2025
GNPX Genprex, Inc. Common Stock, par value $0.001 per share 5% 84,814 Mitchell P. Kopin 28 Oct 2025
AREB American Rebel Holdings, Inc. Common stock, par value $0.001 per share 4.7% $423,088 +$246,261 335,784 +139% Mitchell P. Kopin 30 Jun 2025
ADD Zeta Network Group Class A Ordinary Shares, par value $0.0001 per share 3.7% $76,635 -$31,720 1,094,782 -29% Mitchell P. Kopin 13 Aug 2025
ADIL Adial Pharmaceuticals, Inc. Common stock, par value $0.001 per share 2.8% $281,158 446,282 Mitchell P. Kopin 17 Jun 2025
ENVB Enveric Biosciences, Inc. Common Stock, par value $0.01 per share 0.4% $28,033 -$122,696 19,333 -81% Mitchell P. Kopin 18 Sep 2025
APVO Aptevo Therapeutics Inc. Common stock, par value $0.001 per share 0% $0 0 Mitchell P. Kopin 18 Jun 2025
SLNH Soluna Holdings, Inc. Common stock, par value $0.001 per share 0% $0 -$7,044,795 0 -100% Mitchell P. Kopin 30 Sep 2025
DATS DatChat, Inc. Common stock, par value $0.0001 per share 0% $0 0 Mitchell P. Kopin 08 Jan 2025

Schedules 13D/G Reported by INTRACOASTAL CAPITAL, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.